Compare PAYP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYP | SNN |
|---|---|---|
| Founded | 2018 | 1856 |
| Country | Japan | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Real Estate | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.3B |
| IPO Year | 2026 | N/A |
| Metric | PAYP | SNN |
|---|---|---|
| Price | $20.17 | $30.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $25.54 | ★ $36.25 |
| AVG Volume (30 Days) | ★ 1.2M | 943.6K |
| Earning Date | 08-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | $20.92 | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.80 | $28.02 |
| 52 Week High | $24.89 | $38.79 |
| Indicator | PAYP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 32.56 |
| Support Level | $19.39 | N/A |
| Resistance Level | $22.83 | $33.89 |
| Average True Range (ATR) | 1.08 | 0.61 |
| MACD | -0.12 | -0.28 |
| Stochastic Oscillator | 19.88 | 0.69 |
PayPay Corp is a Japan-based financial technology provider operating a digital finance platform that integrates payments, banking, credit, and investment services for individuals and businesses. Its platform connects users and merchants, facilitating a cashless ecosystem and providing an all-in-one solution for daily financial activities. The company operates in two reportable segments: i) Payment segment and ii) Financial service segment. The majority of the company's revenue is derived from the Financial service segment, which includes internet banking services, securities intermediary services and PayPay Point investment-related services, and loan management services. Geographically, it operates predominantly in Japan.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.